Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma

被引:0
作者
Rong Lin
Chao-qun Han
Wei-jun Wang
Jun Liu
Wei Qian
Zhen Ding
Xiao-hua Hou
机构
[1] Huazhong University of Science and Technology,Department of Gastroenterology, Union Hospital, Tongji Medical College
来源
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2017年 / 37卷
关键词
pancreatic adenocarcinoma; survival; prognosis; lymph node ratio;
D O I
暂无
中图分类号
学科分类号
摘要
Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR≤0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.
引用
收藏
页码:612 / 620
页数:8
相关论文
共 120 条
[31]  
Schwarz RE(2015)Serum CA242, CA199, CA125, CEA, and TSGF are biomarkers for the efficacy and prognosis of cryoablation in pancreatic cancer patients Cell Biochem Biophys 71 1287-241
[32]  
Smith DD(2015)Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection Clin Cancer Res 21 622-351
[33]  
Fujii T(2014)Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy Cancer Chemother Pharmacol 73 1163-401
[34]  
Marmor S(2016)Extent of lymphadenectomy and prognosis after esophageal cancer surgery JAMA Surg 151 32-362
[35]  
Burke EE(2012)Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial J Hepatobiliary Pancreat Sci 19 230-373
[36]  
Portschy PR(2012)Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer World J Surg Oncol 10 77-2596
[37]  
Dasari BV(2015)Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered Einstein (Sao Paulo) 13 347-undefined
[38]  
Pasquali S(2011)Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma J Korean Surg Soc 81 394-undefined
[39]  
Vohra RS(2013)Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma Hepatogastroenterology 60 358-undefined
[40]  
Jang JY(2003)Prognostic factors in the palliation of pancreatic cancer Eur J Surg Oncol 29 368-undefined